Trending
- STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
- What Median OS Did Daraxonrasib Achieve in Pretreated PDAC?
- US Health Secretary Kennedy Distances Himself From FDA’s Replimune Cancer Drug Rejection
- Autogene Cevumeran & The Future of Personalized Cancer Vaccines
- Busting the myths around the Tobacco and Vapes Bill – Cancer Research UK
- Payout for family for dad's asbestos-related death
- Breaking Free from Self-Consciousness and Erythrophobia
- Ozekibart/FOLFIRI Yield Activity in Pretreated Advanced Colorectal Cancer
Wednesday, April 22